Purpose: To report the result of ranibizumab administration in an eye with ocular ischaemic syndrome.
Methods: Fluorescein angiography, ocular pneumoplethysmography and retinal vessel calibre measurement.
Results: An 85-year-old man with ocular ischaemic syndrome demonstrated vision loss, retinal vessel calibre constriction and profound retinal ischaemia after intravitreal ranibizumab.
Conclusion: We advise against the use of intravitreal vascular endothelial growth factor inhibitors in eyes with ocular ischaemic syndrome.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1755-3768.2009.01612.x | DOI Listing |
Publication Analysis
Top Keywords
ocular ischaemic
16
ischaemic syndrome
12
profound retinal
8
retinal ischaemia
8
ranibizumab administration
8
administration eye
8
eye ocular
8
retinal vessel
8
vessel calibre
8
ocular
5
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!